Matrix

Matrix Partners is a venture capital firm established in 1977, with offices in San Francisco, Cambridge, Shanghai, Beijing, Mumbai, and Bangalore. The firm focuses on seed, early-stage, late-stage, and growth capital investments across various sectors, including software, communications, artificial intelligence, fintech, digital health, and clean technology. With a commitment to building long-term relationships with entrepreneurs, Matrix Partners aims to support visionary founders in developing significant, industry-leading companies. The firm has a strong track record, having participated in hundreds of investments, with many of its portfolio companies achieving successful IPOs or profitable mergers and acquisitions. The team at Matrix Partners combines local insights with global expertise, comprising both former entrepreneurs and seasoned investors.

Ben Altshuler

Partner

Tim Barrows

Partner

Diana Kimball Berlin

Partner

Rahul Chaudhary

Venture Partner

Pranay Desai

Managing Director

Phyllis Doherty

Administrative Partner

Paul J. Ferri

Co-Founder

Jacob Jolis

Partner

Patrick Malatack

Partner

Harry Man

Partner

Kojo Osei

Partner

Kun Qian

Managing Director

Brian Ru

Venture Partner

Varun Singhal

Senior Associate

Dana Stalder

General Partner

David Su

Founding Managing Partner

Ilya Sukhar

General Partner

Sun Linghao

Managing Partner

Huadong Wang

Partner

Kevin Xiong

Partner

Michael Zuo

Partner

T.J. Parker

Partner

Past deals in Medical

Qiyi Medical

Seed Round in 2022
Qiyi Medical concentrates on the development of disease management systems and digital diagnosis and treatment products. It solves the core pain points of diagnosis, treatment, and management of chronic respiratory diseases.

Casana

Series B in 2022
Casana is a healthcare technology company focused on heart health monitoring. It has developed the Heart Seat, an innovative product that integrates a toilet seat with a cardiovascular monitoring system. This device allows patients to conveniently track essential heart health metrics such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation from the comfort of their homes. The Heart Seat operates on a cloud-connected platform, enabling seamless data capture and analysis. Founded in 2018 and based in Rochester, New York, Casana aims to enhance heart health monitoring by providing a user-friendly solution that minimizes the need for active patient engagement.

Fuzzy

Series C in 2021
Fuzzy Pet Health, Inc. is a San Francisco-based startup that provides in-home pet healthcare services through a subscription model. Founded in 2016, the company aims to make pet care accessible and affordable for pet owners. Fuzzy offers membership-based nose-to-tail examinations and vaccinations for pets, as well as a mobile application that facilitates real-time communication between pet parents and veterinarians. This app includes features such as Ask-a-Vet mobile chat, electronic health records, and personalized health programs for pets. Additionally, Fuzzy provides a direct mailing service for medications, supplements, and food, ensuring convenience for pet owners. The company was previously known as PetChi, Inc. before rebranding in December 2018.

Huiyi

Seed Round in 2021
Huiyi Health is a comprehensive medical insurance service operator. It is committed to providing services such as optimal medical treatment network, health management, medical equipment welfare, patient assistance, clinical trial recruitment, Internet medical treatment, etc., builds multi-level medical protection for patients, optimizes patient service experience, and promotes Convergence of the pharmaceutical insurance industry.

Centaur Labs

Series A in 2021
Our platform uses trained professionals to analyze medical images and videos, enabling our customers to build new technologies and treatments to detect and fight disease.

Scivita Medical

Series B in 2021
Scivita Medical is a technology-focused enterprise specializing in optical diagnosis and treatment, as well as the development of multidimensional imaging and high-performance materials for minimally invasive medical procedures. The company offers a range of products, including flexible and rigid endoscopes, designed to enhance the capabilities of medical professionals. Its product lineup features advanced technologies such as ultra-high-definition visualization, 3D imaging, and fluorescence visualization, which facilitate precise diagnostics and treatments. Key offerings include a 4K medical endoscope camera system, integrated 4K-3D endoscope systems, and various single-use endoscopic devices for applications in gynecology, urology, and pulmonology. Scivita Medical aims to provide doctors with innovative tools that improve patient outcomes through enhanced visualization and minimally invasive techniques.

UmerDoctor

Series A in 2021
UmerDoctor is a dermatologist collaborative learning platform.

LinkedCare

Series D in 2021
Shanghai LinkedCare Information Technology Co., Ltd. develops oral intelligence management software and integrated management system for dental clinics, medical beauty institutions, and health beauty institutions. It provides dental cloud management software solution, including electronic signature, member management, treatment plan, clinic management analysis, chain management, and inventory management solutions and medical beauty cloud management software solutions that offers marketing extension, member management, cashier system, appointment schedule, and management analysis. The company was founded in 2015 and is based in Shanghai, China.

Reigncom

Series A in 2021
Developer and manufacturer of diagnostic medical devices and reagents. The company is committed to research and development, manufacture and distribution of its diagnostic medical devices, IVD reagent kits and services, such as rapid test products, latex-enhanced immunoturbidimetry products and autoimmune antibodies.

Scivita Medical

Series A in 2021
Scivita Medical is a technology-focused enterprise specializing in optical diagnosis and treatment, as well as the development of multidimensional imaging and high-performance materials for minimally invasive medical procedures. The company offers a range of products, including flexible and rigid endoscopes, designed to enhance the capabilities of medical professionals. Its product lineup features advanced technologies such as ultra-high-definition visualization, 3D imaging, and fluorescence visualization, which facilitate precise diagnostics and treatments. Key offerings include a 4K medical endoscope camera system, integrated 4K-3D endoscope systems, and various single-use endoscopic devices for applications in gynecology, urology, and pulmonology. Scivita Medical aims to provide doctors with innovative tools that improve patient outcomes through enhanced visualization and minimally invasive techniques.

Edda Technology

Private Equity Round in 2021
Developer of a computer-assisted radiology technology designed to enhance efficiency and effectiveness in imaging-guided cancer treatment. The company's technology offers a platform that supports a patient-specific, disease-targeted and multi-disciplinary approach to cancer treatment, enabling physicians to use advanced clinical applications, including automated volumetric organ segmentation and virtual planning and treatment simulation.

QnQuality Pharmaceuticals

Series A in 2021
QnQuality Pharmaceuticals is a new drug research and development specialist for cancer-assisted therapeutics, focusing on unmet clinical needs in the field of oncology supportive care, and is committed to helping cancer patients around the world improve their quality of life. Kuankuo Pharmaceutical has established a rich R&D pipeline covering six indications and a research and development team in China and the United States (

OnQuality Pharmaceuticals

Series A in 2021
OnQuality Pharmaceuticals offers trials to assess the safety and efficacy of a targeted supportive care agent that addresses the specific side effects of vascular endothelial growth factor receptor (VEGFR) inhibitors among cancer patients.

Fuzzy

Series B in 2021
Fuzzy Pet Health, Inc. is a San Francisco-based startup that provides in-home pet healthcare services through a subscription model. Founded in 2016, the company aims to make pet care accessible and affordable for pet owners. Fuzzy offers membership-based nose-to-tail examinations and vaccinations for pets, as well as a mobile application that facilitates real-time communication between pet parents and veterinarians. This app includes features such as Ask-a-Vet mobile chat, electronic health records, and personalized health programs for pets. Additionally, Fuzzy provides a direct mailing service for medications, supplements, and food, ensuring convenience for pet owners. The company was previously known as PetChi, Inc. before rebranding in December 2018.

Remebot

Series D in 2020
Beijing Remebot Technology Co., Ltd. engages in research, development, production, and sales of medical robots. The company is based in Beijing, China.

Weimai

Series C in 2020
Weimai is a developer of a health application platform intended to provide medical and health services. The company's health application platform offers an Internet-based appointment, distribution, maternal and child disease management, grading diagnosis and treatment as well as remote diagnosis, and medical records management, providing users with a family doctor application in every home.

D3 Bio

Series A in 2020
D3 Bio Inc. is a biotechnology company founded in 2020 and based in China. It specializes in the development and registration of innovative medicines, primarily focusing on oncology and immunology. The company adopts a unique approach to medicine development by first identifying significant unmet patient and market needs, particularly in areas where current treatments are inadequate. This understanding informs their research and guides the selection of appropriate scientific and technological methods to define their drug development strategy. Through this differentiated approach, D3 Bio aims to address critical health challenges and improve clinical outcomes for patients.

Practo

Series D in 2020
Practo Technologies Private Limited operates a comprehensive healthcare platform that connects patients with healthcare providers globally. Established in 2008 and headquartered in Bengaluru, India, Practo offers a range of services to meet diverse healthcare needs, including finding doctors, booking appointments, accessing online consultations, scheduling diagnostic tests, and ordering medicines. The platform also features Practo Ray, a subscription-based practice management software for healthcare professionals, and Practo Reach, a service that enhances visibility for hospitals and clinics. With additional offices in major Indian cities and locations in Southeast Asia and Brazil, Practo aims to facilitate better healthcare management by allowing users to store health records, consult doctors online, and engage with healthcare services more effectively.

Peijia Medical

Series C in 2019
Peijia Medical Limited specializes in the research, development, production, and sales of interventional medical devices aimed at treating structural heart and neurovascular diseases. Founded in 2012 and based in Suzhou, China, the company offers a range of transcatheter aortic valve replacement (TAVR) products, including its TaurusOne, TaurusElite, and TaurusNXT systems. Additionally, Peijia is advancing the development of transcatheter mitral and tricuspid valve replacement devices, as well as ancillary products such as lithotripsy and balloon aortic valvuloplasty catheters. The company also produces neurointerventional products, including stent retrievers and various catheter types designed for complex vascular procedures. With a focus on both transcatheter valve therapeutic and neurointerventional markets, Peijia Medical operates from a modern facility that combines advanced technology with an aesthetically pleasing design, reflecting its commitment to innovation in the medical device industry.

QnQuality Pharmaceuticals

Series A in 2019
QnQuality Pharmaceuticals is a new drug research and development specialist for cancer-assisted therapeutics, focusing on unmet clinical needs in the field of oncology supportive care, and is committed to helping cancer patients around the world improve their quality of life. Kuankuo Pharmaceutical has established a rich R&D pipeline covering six indications and a research and development team in China and the United States (

OnQuality Pharmaceuticals

Series A in 2019
OnQuality Pharmaceuticals offers trials to assess the safety and efficacy of a targeted supportive care agent that addresses the specific side effects of vascular endothelial growth factor receptor (VEGFR) inhibitors among cancer patients.

Yaeher Health

Series A in 2019
Shenzhen Yaeher Health Management Co., Ltd. is a healthcare service provider based in Shenzhen, China, founded in 2016. The company focuses on maternal and child health, offering consultation services through its evidence-based medicine platform. By utilizing a structured approach to healthcare, Yaeher Health aims to enhance the well-being of mothers and children, ensuring access to reliable and informed health guidance.

Fuzzy

Series A in 2019
Fuzzy Pet Health, Inc. is a San Francisco-based startup that provides in-home pet healthcare services through a subscription model. Founded in 2016, the company aims to make pet care accessible and affordable for pet owners. Fuzzy offers membership-based nose-to-tail examinations and vaccinations for pets, as well as a mobile application that facilitates real-time communication between pet parents and veterinarians. This app includes features such as Ask-a-Vet mobile chat, electronic health records, and personalized health programs for pets. Additionally, Fuzzy provides a direct mailing service for medications, supplements, and food, ensuring convenience for pet owners. The company was previously known as PetChi, Inc. before rebranding in December 2018.

Weimai

Series C in 2019
Weimai is a developer of a health application platform intended to provide medical and health services. The company's health application platform offers an Internet-based appointment, distribution, maternal and child disease management, grading diagnosis and treatment as well as remote diagnosis, and medical records management, providing users with a family doctor application in every home.

Abc clinic butler

Angel Round in 2019
Abc Clinic Manager is a smart clinic butler service provider that provides a complete set of business process tools for clinics and community hospitals, including core medical records, general diagnostics, drug management, chain operations and other core services (HIS/CIS) to help clinics improve Business efficiency and operational efficiency. At the same time, ABC clinic butler also developed a medical AI service (CDSS) based on big data on the cloud, which helps the grassroots doctors to easily get the help of the expert brain, improve the quality of diagnosis and treatment, and reduce the risk of doctors and patients.

Ruixin Smart Medical

Series A in 2019
Ruixin Smart Medical develops real-time monitoring equipment for the detection of cardiovascular and cerebrovascular diseases. It is researching and developing intelligent medical platforms based on artificial intelligence, simulation, and cloud computing, so as to deeply mine the information in medical data to more accurately assess the condition and guide treatment. The company was founded in 2017 and is headquartered in Shenzhen.
Beijing Haoshi Technology is a smart medical marketing SaaS service provider

Myra

Venture Round in 2018
We believe in creating a healthier tomorrow without having to struggle physically or financially today. Headquartered in Bangalore, we operate our own warehouses (full stack) to ensure the best quality of medicines to our customers without compromising on the experience. We are voted among the top 17 startups to watch out for in 2017.

Weimai

Series B in 2018
Weimai is a developer of a health application platform intended to provide medical and health services. The company's health application platform offers an Internet-based appointment, distribution, maternal and child disease management, grading diagnosis and treatment as well as remote diagnosis, and medical records management, providing users with a family doctor application in every home.

SoYoung

Series E in 2018
SoYoung International Inc, based in Beijing, operates an online platform for discovering and booking medical aesthetic services in China. With its app having garnered 10 million downloads, the company aims to partner with 200 clinics and thousands of plastic surgeons over the next three years, capitalizing on a burgeoning aesthetic medical services market projected to reach $11.3 billion within five years. The business model encompasses several components, including the distribution of professional content through social media, a community driven by user-generated content, online reservation services for aesthetic treatments, and the development and sales of laser and other medical beauty equipment. SoYoung generates revenue through information service fees and reservation service fees from medical aesthetic providers, positioning itself at the intersection of technology and healthcare in a rapidly evolving industry.

UP Clinic

Series A in 2018
UP Clinic is a specialized provider of orthopedic rehabilitation and sports medicine services. The clinic operates a network of facilities equipped with advanced medical technology and staffed by professional medical experts. It focuses on delivering comprehensive care for sports enthusiasts, orthopedic patients, postoperative individuals, and those experiencing sub-health conditions. By offering specialized treatments in sports medicine and musculoskeletal rehabilitation, UP Clinic aims to address the diverse needs of its patients and enhance their recovery and overall well-being.

Chemclin

Private Equity Round in 2018
Beijing Chemclin Biotech Co., Ltd. specializes in the development, production, and sales of diagnostic reagents and instruments for clinical use. Founded in 1999 and based in Beijing, China, the company focuses on in-vitro diagnostics, offering a range of products including reagents for infectious diseases, tumor markers, and thyroid and diabetes testing. Chemclin also provides semi-automated and fully automated chemiluminescent analyzers, which facilitate the performance of chemiluminescent assays. Additionally, the company offers commercial testing services for various health conditions, including liver fibrosis and fertility. As a subsidiary of China Diagnostics Medical Corporation, Chemclin is committed to delivering innovative diagnostic solutions and services to the Chinese healthcare market.

GrandOmics

Series B in 2018
Grandomics Biosciences Co., Ltd. is a precision medical company based in Beijing, China, specializing in genetic sequencing and diagnosis. Founded in 2014, Grandomics offers a range of solutions for monogenic diseases, including Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), and multiplex ligation-dependent probe amplification. The company also focuses on specific disorders such as facioscapulohumeral muscular dystrophy. In addition to these diagnostic services, Grandomics provides advanced sequencing platforms like Oxford Nanopore and Pacbio Sequel, along with GrandBox™, a software suite for clinical sample management and data analysis. This integrated approach enables comprehensive genetic testing and carrier screening, positioning Grandomics as a key player in the field of molecular diagnosis and genetic research.

Yaeher Health

Series A in 2018
Shenzhen Yaeher Health Management Co., Ltd. is a healthcare service provider based in Shenzhen, China, founded in 2016. The company focuses on maternal and child health, offering consultation services through its evidence-based medicine platform. By utilizing a structured approach to healthcare, Yaeher Health aims to enhance the well-being of mothers and children, ensuring access to reliable and informed health guidance.

SoYoung

Series D in 2018
SoYoung International Inc, based in Beijing, operates an online platform for discovering and booking medical aesthetic services in China. With its app having garnered 10 million downloads, the company aims to partner with 200 clinics and thousands of plastic surgeons over the next three years, capitalizing on a burgeoning aesthetic medical services market projected to reach $11.3 billion within five years. The business model encompasses several components, including the distribution of professional content through social media, a community driven by user-generated content, online reservation services for aesthetic treatments, and the development and sales of laser and other medical beauty equipment. SoYoung generates revenue through information service fees and reservation service fees from medical aesthetic providers, positioning itself at the intersection of technology and healthcare in a rapidly evolving industry.

SoYoung

Series D in 2017
SoYoung International Inc, based in Beijing, operates an online platform for discovering and booking medical aesthetic services in China. With its app having garnered 10 million downloads, the company aims to partner with 200 clinics and thousands of plastic surgeons over the next three years, capitalizing on a burgeoning aesthetic medical services market projected to reach $11.3 billion within five years. The business model encompasses several components, including the distribution of professional content through social media, a community driven by user-generated content, online reservation services for aesthetic treatments, and the development and sales of laser and other medical beauty equipment. SoYoung generates revenue through information service fees and reservation service fees from medical aesthetic providers, positioning itself at the intersection of technology and healthcare in a rapidly evolving industry.

12 Sigma Technologies

Series B in 2017
12 Sigma Technologies, founded in April 2015, is a healthcare company that focuses on modern medical image diagnosis and data analysis. The firm leverages advanced artificial intelligence technologies to enhance medical imaging applications, believing in the significant potential of integrating AI with medical imaging. To further its mission, 12 Sigma has established partnerships with General Electric to co-develop innovative diagnostic products targeting tumors, cardiovascular diseases, and CT scans. Additionally, the company collaborates with over 50 leading hospitals in China, engaging in applied medical diagnostics, technical research, and clinical trials to advance its healthcare solutions.

DocTalk

Seed Round in 2017
DocTalk Solutions India Private Limited develops and offers a mobile application that enables patients to communicate with their doctors. The company's application enables users to chat with their doctor, save medical reports, and get prescriptions. DocTalk Solutions India Private Limited was founded in 2016 and is based in Mumbai, India.

U-Dental

Series B in 2017
Shenzhen U-dental Corporation Limited operates a dental care facility in China, providing a wide range of dental services. These include preventative care like cleanings, sealants, digital X-rays, and fluoride treatments, alongside orthodontics such as braces and Invisalign. The clinic also specializes in oral surgery, particularly third molar extractions and dental implants. Pediatric dentistry services are offered, including cosmetic treatments, ceramic onlays, and composite fillings. Additionally, U-dental provides endodontic services like root canals and retreatments, as well as periodontics, which encompass grafts, crown lengthening, and scaling. The company also focuses on specialty training programs in implants and orthodontic care. Founded in 2006, U-dental is headquartered in Shenzhen, China.

Distinct HealthCare

Series C in 2017
Distinct Healthcare operates a network of approximately 20 private healthcare clinics across six cities in China, including Shenzhen, Hong Kong, Guangzhou, and Beijing. The company specializes in a range of medical services, including pediatrics, internal medicine, gynecology, and family medicine, addressing common health issues such as respiratory infections, diabetes, and hypertension. Distinct Healthcare also provides emergency support, facilitating hospital admissions and specialist referrals. In addition to clinical care, the company offers comprehensive examination and laboratory tests, including imaging and blood analysis, as well as nursing services such as aerosol therapy and home nursing. Founded in 2012, Distinct Healthcare emphasizes patient-oriented care and quality assurance, with a focus on appropriate treatment recommendations and minimizing unnecessary medical interventions. The company has established a strategic partnership with Tencent Holdings Limited to enhance its services.

BOSHI

Series A in 2017
Developer of a medical big data analysis platform. The company's professional-level patient information management and big data analysis system are committed to providing in-depth analysis, enabling doctors to do scientific and clinical research more efficiently.

Weiming Penguin

Series A in 2017
Provider of a third-party trading platform designed to offer medicine, equipment and health care products. The company's platform focuses on online channels for direct access terminals for pharmaceutical companies and commercial companies, enabling customers to meet their needs and improve the quality of life.

12 Sigma Technologies

Series A in 2017
12 Sigma Technologies, founded in April 2015, is a healthcare company that focuses on modern medical image diagnosis and data analysis. The firm leverages advanced artificial intelligence technologies to enhance medical imaging applications, believing in the significant potential of integrating AI with medical imaging. To further its mission, 12 Sigma has established partnerships with General Electric to co-develop innovative diagnostic products targeting tumors, cardiovascular diseases, and CT scans. Additionally, the company collaborates with over 50 leading hospitals in China, engaging in applied medical diagnostics, technical research, and clinical trials to advance its healthcare solutions.

Anxin Doctor

Series B in 2017
Anxin Doctor is a mobile healthcare platform focused on maternal and pediatric health. It connects patients with obstetricians, gynecologists, and pediatricians through its application, which facilitates access to healthcare advice and clinical appointment bookings. By bridging the gap between patients and healthcare professionals, Anxin Doctor aims to enhance health outcomes for mothers and children, ensuring timely and efficient medical care.

Weiming Penguin

Series A in 2017
Provider of a third-party trading platform designed to offer medicine, equipment and health care products. The company's platform focuses on online channels for direct access terminals for pharmaceutical companies and commercial companies, enabling customers to meet their needs and improve the quality of life.

Practo

Series D in 2017
Practo Technologies Private Limited operates a comprehensive healthcare platform that connects patients with healthcare providers globally. Established in 2008 and headquartered in Bengaluru, India, Practo offers a range of services to meet diverse healthcare needs, including finding doctors, booking appointments, accessing online consultations, scheduling diagnostic tests, and ordering medicines. The platform also features Practo Ray, a subscription-based practice management software for healthcare professionals, and Practo Reach, a service that enhances visibility for hospitals and clinics. With additional offices in major Indian cities and locations in Southeast Asia and Brazil, Practo aims to facilitate better healthcare management by allowing users to store health records, consult doctors online, and engage with healthcare services more effectively.

Baiyee

Angel Round in 2017
Developer of an online supply chain management platform for medical supplies. The company's platform helps clients track logistic status, manage storage, and ensure timely delivery, enabling clients to get access to sufficient medical supplies.

GrandOmics

Venture Round in 2016
Grandomics Biosciences Co., Ltd. is a precision medical company based in Beijing, China, specializing in genetic sequencing and diagnosis. Founded in 2014, Grandomics offers a range of solutions for monogenic diseases, including Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), and multiplex ligation-dependent probe amplification. The company also focuses on specific disorders such as facioscapulohumeral muscular dystrophy. In addition to these diagnostic services, Grandomics provides advanced sequencing platforms like Oxford Nanopore and Pacbio Sequel, along with GrandBox™, a software suite for clinical sample management and data analysis. This integrated approach enables comprehensive genetic testing and carrier screening, positioning Grandomics as a key player in the field of molecular diagnosis and genetic research.

UNIMED

Series B in 2016
Tongxin Yilian Technology (Beijing) Co., Ltd. develops online medical treatment system, Unimed. The company is based in Beijing, China.

Weiming Penguin

Angel Round in 2016
Provider of a third-party trading platform designed to offer medicine, equipment and health care products. The company's platform focuses on online channels for direct access terminals for pharmaceutical companies and commercial companies, enabling customers to meet their needs and improve the quality of life.

Zhangshang Tangyi

Series B in 2016
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Wingspan

Series B in 2016
Wingspan Technology Ltd., founded in 2009 and based in Beijing, China, specializes in digital medical imaging solutions. The company has developed a cloud-based diagnostic platform designed to transform traditional medical imaging services. By leveraging mobile Internet technology, Wingspan offers comprehensive medical imaging systems that facilitate end-to-end services. Utilizing advanced deep learning networks, the platform analyzes millions of scans to autonomously identify diseases, thereby enhancing the diagnostic capabilities of healthcare professionals. This innovative approach aims to improve patient outcomes by enabling more effective diagnoses.

Peijia Medical

Series A in 2016
Peijia Medical Limited specializes in the research, development, production, and sales of interventional medical devices aimed at treating structural heart and neurovascular diseases. Founded in 2012 and based in Suzhou, China, the company offers a range of transcatheter aortic valve replacement (TAVR) products, including its TaurusOne, TaurusElite, and TaurusNXT systems. Additionally, Peijia is advancing the development of transcatheter mitral and tricuspid valve replacement devices, as well as ancillary products such as lithotripsy and balloon aortic valvuloplasty catheters. The company also produces neurointerventional products, including stent retrievers and various catheter types designed for complex vascular procedures. With a focus on both transcatheter valve therapeutic and neurointerventional markets, Peijia Medical operates from a modern facility that combines advanced technology with an aesthetically pleasing design, reflecting its commitment to innovation in the medical device industry.

ET Healthcare

Series B in 2015
ET Healthcare, Inc. is an in vitro diagnostics company that specializes in manufacturing central laboratory analyzers for both inpatient and outpatient testing in various medical settings, including hospitals and clinics. The company has developed the Pylon Immunochemistry System, an integrated turnkey solution that addresses the immunodiagnostics needs across several areas, such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, the Pylon BNP Immunoassay aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. ET Healthcare’s offerings include a variety of immunoassays for cardiac markers, blood clots, and other health conditions, facilitating simplified blood analysis for physicians. Based in Palo Alto, California, the company also has offices in Shanghai, China, and operates manufacturing facilities in Suzhou, China.

Zhangshang Tangyi

Series A in 2015
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Genedock

Angel Round in 2015
GeneDock, founded in September 2014, is a national high-tech enterprise specializing in precision medical data technology. The company develops and provides a comprehensive SaaS platform that allows users to extract, analyze, and visualize medical records, facilitating improved research and studies for medical and scientific institutions. With industry-leading expertise, GeneDock has successfully built data platforms for numerous prominent facilities, including top three hospitals and leading industry organizations in China. The core team comprises members with backgrounds from renowned companies, and the firm has attracted investment from notable institutions. GeneDock aims to drive innovation in healthcare through advanced data technology solutions.

UNIMED

Series A in 2015
Tongxin Yilian Technology (Beijing) Co., Ltd. develops online medical treatment system, Unimed. The company is based in Beijing, China.

Vdaifu

Series B in 2015
Vdaifu provides services on online bookings of pediatric healthcare and doctors.

Distinct HealthCare

Series B in 2015
Distinct Healthcare operates a network of approximately 20 private healthcare clinics across six cities in China, including Shenzhen, Hong Kong, Guangzhou, and Beijing. The company specializes in a range of medical services, including pediatrics, internal medicine, gynecology, and family medicine, addressing common health issues such as respiratory infections, diabetes, and hypertension. Distinct Healthcare also provides emergency support, facilitating hospital admissions and specialist referrals. In addition to clinical care, the company offers comprehensive examination and laboratory tests, including imaging and blood analysis, as well as nursing services such as aerosol therapy and home nursing. Founded in 2012, Distinct Healthcare emphasizes patient-oriented care and quality assurance, with a focus on appropriate treatment recommendations and minimizing unnecessary medical interventions. The company has established a strategic partnership with Tencent Holdings Limited to enhance its services.

Vdaifu

Series A in 2014
Vdaifu provides services on online bookings of pediatric healthcare and doctors.

QPID

Series B in 2014
QPID Health, Inc. is a healthcare IT software company that provides a health record intelligence platform designed to enhance the use of electronic health records (EHRs) in clinical settings. The company's flagship product, the Queriable Programmable Inference Dossier (QPID), enables healthcare institutions to generate clinician-directed queries, analytics, and reporting in real time, facilitating improved decision-making at the point of care. Developed initially at Massachusetts General Hospital, the QPID platform utilizes natural language processing and machine learning to deliver context-sensitive information from patient records, thereby increasing clinician productivity and supporting better patient outcomes. QPID Health is headquartered in Boston, Massachusetts, with an additional location in San Diego, California. The company aims to maximize the value of EHR investments and streamline quality reporting and clinical registry submissions, ultimately helping healthcare providers reduce costs and meet quality goals.

ET Healthcare

Series A in 2014
ET Healthcare, Inc. is an in vitro diagnostics company that specializes in manufacturing central laboratory analyzers for both inpatient and outpatient testing in various medical settings, including hospitals and clinics. The company has developed the Pylon Immunochemistry System, an integrated turnkey solution that addresses the immunodiagnostics needs across several areas, such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, the Pylon BNP Immunoassay aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. ET Healthcare’s offerings include a variety of immunoassays for cardiac markers, blood clots, and other health conditions, facilitating simplified blood analysis for physicians. Based in Palo Alto, California, the company also has offices in Shanghai, China, and operates manufacturing facilities in Suzhou, China.

SoYoung

Series A in 2014
SoYoung International Inc, based in Beijing, operates an online platform for discovering and booking medical aesthetic services in China. With its app having garnered 10 million downloads, the company aims to partner with 200 clinics and thousands of plastic surgeons over the next three years, capitalizing on a burgeoning aesthetic medical services market projected to reach $11.3 billion within five years. The business model encompasses several components, including the distribution of professional content through social media, a community driven by user-generated content, online reservation services for aesthetic treatments, and the development and sales of laser and other medical beauty equipment. SoYoung generates revenue through information service fees and reservation service fees from medical aesthetic providers, positioning itself at the intersection of technology and healthcare in a rapidly evolving industry.

TechMed Healthcare

Venture Round in 2013
TechMed Healthcare is a modern healthcare organization focused on promoting preventive healthcare to enhance overall well-being. It recognizes the challenges posed by contemporary lifestyles, particularly for those with familial health issues, and addresses the confusion often caused by excessive health information available in the media. The organization prioritizes understanding individual health statuses and susceptibility to diseases, employing advanced technology for accurate diagnostics and early intervention. TechMed Healthcare operates a hospital lab management pathology chain that provides timely laboratory testing, diagnostic services, and imaging, enabling healthcare providers to efficiently deliver test results and improve patient care. Its team comprises highly trained medical professionals dedicated to making healthcare accessible and affordable for everyone, emphasizing the importance of health maintenance as a pathway to happiness.
Beijing Jingcheng Boai Rehabilitation Hospital owns and operates an integrated Chinese and western medicine rehabilitation hospital. The company is based in Beijing, China.

Reach Surgical

Venture Round in 2013
Reach Surgical (Beijing), Inc. specializes in the design and development of medical devices and surgical equipment, focusing on high-quality instruments for various surgical applications. The company's product portfolio includes open staplers, linear staplers, and linear cutters, which are utilized in abdominal, gynecological, thoracic, and pediatric surgeries for procedures such as tissue resection and anastomosis. Additionally, Reach Surgical offers endoscopic staplers and procedure sets specifically designed for treating prolapse and hemorrhoids. All products have received approvals from the US FDA and the EU CE, ensuring compliance with international safety standards. With research and development centers in Cincinnati, Beijing, and Shanghai, Reach Surgical aims to provide advanced and minimally invasive surgical solutions to clinicians worldwide. Established in 2005, the company operates a distribution network in China and internationally, striving to enhance surgical efficiency and outcomes for healthcare professionals.

Meditrina Hospital

Series A in 2013
Meditrina Hospital, the second venture of Meditrina Group, Is being launched at pattom, Thiruvananthapuram. The initial Endeavour, meditrina Cardiac centre has already Positioned in the history of Kerala in the opening year itself through the highest Number of Angioplasties performed. And it is functioning successfully in conjunction With a solid commitment for public welfare and no attention to monetary benefit. Meditrina Group now initiates its second project at Thiruvananthapuram Amongst more than a dozen of specialty hospitals. Meditrina Hospital stands Apart by bringing together world class medical facilities, highly qualified, Nationally and internationally experienced doctors with Social commitment ensuring affordable cost of treatment. Creating this rare combination in the field of medicine, The new venture looks forward to meet the highest possible Standards of efficiency and ensures the best Treatment in India. And we proudly initiates coronary Angioplasty perfected with The use of Intra Vascular Ultra Sound and Fractional Flow-Wire, This is rarely done even in the major institutions. Holding a high Standard of medical ethics, Meditrina Hospital assures its services to be made available Equitably on the basis of need.

QPID

Series A in 2013
QPID Health, Inc. is a healthcare IT software company that provides a health record intelligence platform designed to enhance the use of electronic health records (EHRs) in clinical settings. The company's flagship product, the Queriable Programmable Inference Dossier (QPID), enables healthcare institutions to generate clinician-directed queries, analytics, and reporting in real time, facilitating improved decision-making at the point of care. Developed initially at Massachusetts General Hospital, the QPID platform utilizes natural language processing and machine learning to deliver context-sensitive information from patient records, thereby increasing clinician productivity and supporting better patient outcomes. QPID Health is headquartered in Boston, Massachusetts, with an additional location in San Diego, California. The company aims to maximize the value of EHR investments and streamline quality reporting and clinical registry submissions, ultimately helping healthcare providers reduce costs and meet quality goals.

Distinct HealthCare

Series A in 2012
Distinct Healthcare operates a network of approximately 20 private healthcare clinics across six cities in China, including Shenzhen, Hong Kong, Guangzhou, and Beijing. The company specializes in a range of medical services, including pediatrics, internal medicine, gynecology, and family medicine, addressing common health issues such as respiratory infections, diabetes, and hypertension. Distinct Healthcare also provides emergency support, facilitating hospital admissions and specialist referrals. In addition to clinical care, the company offers comprehensive examination and laboratory tests, including imaging and blood analysis, as well as nursing services such as aerosol therapy and home nursing. Founded in 2012, Distinct Healthcare emphasizes patient-oriented care and quality assurance, with a focus on appropriate treatment recommendations and minimizing unnecessary medical interventions. The company has established a strategic partnership with Tencent Holdings Limited to enhance its services.

I-MD

Series A in 2012
I-MD is a physician-oriented professional service platform targeting certificated doctors as well as medical college students and resident doctors without a practicing certificate. It develops products and services, including document services that provide every physician with free open and online reading and downloading services by integrating major medical document databases at home and abroad, and designated inspections for some physicians; many-to-one/many-to-many online interactive academic video conferences services such as medical academic conferences, product explanation meetings, academy seminars/symposia, and more, enabling real-time and remote one-to-many and many-to-many multi-media interactive conferences; professional information such as the latest medical industry and health policy information, medical research, and development and clinical updates, medicine information, diagnosis and treatment guidelines, and clinical cases at home and abroad.

iKang Healthcare

Series B in 2007
iKang Healthcare Group, Inc. is a leading provider of preventive healthcare solutions in China, operating primarily through two segments: Medical Examinations and Other Medical Services, including Dental Services. The company offers a comprehensive array of medical examinations, covering areas such as internal medicine, gynecology, ophthalmology, ENT, and various diagnostic tests like lab work, electrocardiograms, ultrasound, and X-rays. Additionally, iKang provides value-added services including disease screenings focused on cancer, cardiovascular health, and chronic disease management, along with dental care services ranging from oral health to orthodontics. The company serves both corporate and individual customers through a network of 113 self-owned medical centers located in 33 cities across China, complemented by approximately 400 third-party facilities. iKang aims to deliver personalized health management services, collaborating with numerous enterprises, insurance companies, and government departments to enhance public health outcomes. The company is headquartered in Beijing and was formed through the merger of ICON and Guobin Medical Treatment Holding.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.